You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


UK biotech Ixaka scores additional funding for cell and gene therapy research

London, UK-based integrated cell and gene therapy company Ixaka – formerly Rexgenero – has launched with additional financing from existing shareholders totalling over £40m.